Search

Author/Creator Milligan, S.

1. Changing HCV patient profiles: insights from a large multinational real-world sofosbuvir/velpatasvir (SOF/VEL) dataset. (March 2023)

Authors:
Mangia, A.; Fagiuoli, S.; Di Marco, V.; Shafran, S.; Khalili, M.; Milligan, S.; Papatheodoridis, G.; Ouzan, D.; Rosati, S.; Ramji, A.; Teti, E.; Garcia-Retortillo, M.; Hernandez, F. Andres Perez; Wong, A.; Fraser, C.; Rodriguez-Tajes, S.; Mutiloa, E. Jimenèz; Amado, L. Enrique Morano; O'Loan, J...
Journal:
Digestive and liver disease
Issue:
Volume 55(2023)Supplement 1
Page Start:
S71
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Effectiveness of 8‐ or 12‐weeks of ledipasvir and sofosbuvir in real‐world treatment‐naïve, genotype 1 hepatitis C infected patients. Issue 5 (10th July 2017)

Authors:
Curry, M. P.; Tapper, E. B.; Bacon, B.; Dieterich, D.; Flamm, S. L.; Guest, L.; Kowdley, K. V.; Lee, Y.; Milligan, S.; Tsai, N.; Younossi, Z.; Afdhal, N. H.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 46:Issue 5(2017)
Page Start:
540
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗